0001437749-17-002063.txt : 20170209
0001437749-17-002063.hdr.sgml : 20170209
20170209205401
ACCESSION NUMBER: 0001437749-17-002063
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170207
FILED AS OF DATE: 20170209
DATE AS OF CHANGE: 20170209
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACELRX PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001427925
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 351 GALVESTON DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-216-3500
MAIL ADDRESS:
STREET 1: 351 GALVESTON DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mitchell Jane Wright
CENTRAL INDEX KEY: 0001614568
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35068
FILM NUMBER: 17589260
MAIL ADDRESS:
STREET 1: C/0 ACELRX PHARMACEUTICALS, INC.
STREET 2: 351 GALVESTON DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
rdgdoc.xml
FORM 4
X0306
4
2017-02-07
0001427925
ACELRX PHARMACEUTICALS INC
ACRX
0001614568
Mitchell Jane Wright
C/O ACELRX PHARMACEUTICALS, INC.
351 GALVESTON DRIVE
REDWOOD CITY
CA
94063
1
Chief Legal Officer
Common Stock (Right to Buy)
3
2017-02-07
4
A
0
79500
0
A
2018-02-07
2028-02-06
Common Stock
79500
79500
D
Issued pursuant to the 2011 Equity Incentive Plan.
The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the Vesting Commencement Date (February 7, 2017) and the remaining shares subject to the option vest on an equal monthly basis over the following 36 months.
100% Acceleration upon Change of Control.
/s/ Martha Adler, Attorney-in-Fact
2017-02-09